Parkinson's Disease Biomarker Innovation and Advancement Program
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
Browse similar grants
Funder: Michael J. Fox Foundation for Parkinson's Research
Due Dates: Rolling (pre-proposals) | By invitation, next available review cycle (full proposals)
Funding Amounts: Funding contingent on project scope and development stage; support for up to 24 months
Summary: Supports development of reproducible fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson’s research.
Key Information: Academic- or nonprofit-led applications require a substantive commercial assay platform partner able to support use beyond the originating laboratory.
Description
The Michael J. Fox Foundation (MJFF) runs this program to accelerate robust, reproducible measurement tools with defined contexts of use in Parkinson’s disease. It supports teams mapping and measuring disease biology and translating priority fluid- and imaging-based biomarkers into validated, fit-for-purpose tools accessible to the broader Parkinson’s research community.
The program prioritizes biomarker technologies aligned with MJFF priorities and intended for clinical implementation. Proposals must include relevant clinical data, a clear commercialization plan, and arrangements that enable access beyond the originating laboratory. Through a continuous submission pathway, teams can seek an initial assessment of their project’s alignment before being invited to submit a full proposal.
